Covid-19 and IBD

While COVID-19 rages across the globe in this unprecedented pandemic that has drug on for almost a year, hundreds of thousands of people globally are still wondering how this could impact their IBD. Here is what Dr. Gil Y. Melmend MD, MS co-director of the Inflammatory Bowel Disease Center in Los Angeles, California had to … Read more

2020 Year Review: Ulcerative Colitis

While 2020 was challenging to say the least, we did see positives in the advancement of treatments for patients with ulcerative colitis. This comes as welcome news for many, with about 38,000 people a year diagnosed with UC. From new biologics, topical medicines, and immune modulators, ever growing research is supporting these treatments and more. … Read more

IBD vs. IBS

If you’re new to the world of IBD it may be confusing to differentiate IBD from IBS. They are after all both known to cause gut chaos, abdominal pain, and have a varying degree of severity depending on the person. This is however where the similarities end. In the following paragraphs we will cover their … Read more

New Wrist Watch-like Device Could Help Improve Monitoring of IBD

Researchers at The University of Texas at Dallas, funded by the Crohn’s & Colitis Foundation, have designed a wrist watch-like device that monitors two important biomarkers associated with IBD flare ups through sweat. Having these two biomarkers present doesn’t necessarily mean the patient will flare, but it can give the chance to intervene earlier making … Read more

Phase 3 Study Finds Zeposia Effective in UC Remission

As more and more drugs come to market for autoimmune disorders the market gets fiercer and demanding. The current sweet spot? Taking autoimmune therapies from intravenous to pill form. This is seen across a wide range of autoimmune diseases from Multiple Sclerosis (MS) to IBD and everything in between.   Zeposia was FDA approved for treatment … Read more